For a patient weighing 220 pounds, semaglutide might produce 22-33 pounds of weight loss, while tirzepatide might achieve 33-48 pounds
Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses
Leader in autoimmune diagnostics Vibrant strives to become the leader in autoimmune diagnostics
Importantly, initiation of GLP-1RA may decrease levothyroxine dose requirements in patients with hypothyroidism through weight loss, enhance levothyroxine absorption due to delayed gastrointestinal (GI) transit, and have direct effects on the hypothalamic-pituitary-thyroid axis [23,24,25,26,27,28,29], potentially increasing the risk of thyroid hormone over-replacement (i.e., iatrogenic hyperthyroidism)